Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (HK:2252) has released an update.
Shanghai MicroPort MedBot (Group) Co., Ltd. has reported a significant reduction in net loss to RMB 280 million for the first half of 2024, down from RMB 544.7 million in the same period last year, driven by strong sales of its core products like Toumai and SkyWalker robots, and effective cost reduction strategies. Despite this improvement, the company experienced a net free cash outflow of RMB 235.3 million, a 49.7% decrease from the previous year, indicating better financial management and increased efficiency. The company’s revenue nearly doubled, signaling promising growth and market expansion.
For further insights into HK:2252 stock, check out TipRanks’ Stock Analysis page.
